Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second-line therapy in pediatric chronic myeloid leukemia

Sembill S, Zerjatke T, Winterstein M, Ghete T, Schirmer E, Wotschofsky Z, Suttorp M, Krumbholz M, Karow A, Glauche I, Metzler M (2026)

Publication Type: Journal article

Publication year: 2026

Journal

HemaSphere Lippincott, Williams & Wilkins

Book Volume: 10

Article Number: e70347

Journal Issue: 3

DOI: 10.1002/hem3.70347

Authors with CRIS profile

Stephanie Sembill Department of Paediatrics and Adolescent Medicine Denisia-Tabita Ghete Department of Paediatrics and Adolescent Medicine Manuela Krumbholz Department of Paediatrics and Adolescent Medicine Axel Karow Medizinische Fakultät Markus Metzler Professur für Kinder- und Jugendmedizin mit dem Schwerpunkt Pädiatrische Onkologie und Hämatologie

Involved external institutions

Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE)

How to cite

APA:

Sembill, S., Zerjatke, T., Winterstein, M., Ghete, T., Schirmer, E., Wotschofsky, Z.,... Metzler, M. (2026). Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second-line therapy in pediatric chronic myeloid leukemia. HemaSphere, 10(3). https://doi.org/10.1002/hem3.70347

MLA:

Sembill, Stephanie, et al. "Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second-line therapy in pediatric chronic myeloid leukemia." HemaSphere 10.3 (2026).

BibTeX: Download